HOME >> MEDICINE >> NEWS
Mayo Clinic researchers discover how key cancer protein works

ROCHESTER, Minn. -- Mayo Clinic researchers are the first to describe what goes wrong during the growth cycle of certain cells that can lead to inherited forms of breast cancer. Knowing the nature of this biochemical modification is a first step to designing drugs that can correct it to stop cancer.

The Mayo Clinic research finding appears in today's issue of the journal Science (www.sciencemag.org/content/current ). It is important because it solves an aspect of a mystery that cancer researchers worldwide have been intensely investigating. Their question is: How do the regulating mechanisms of the "cell-cycle" work?

The cell cycle is the complex, natural -- and normally orderly -- process by which cells reproduce. The Mayo Clinic research reveals the details of a molecular mechanism involved in cell cycle regulation of a gene known as the "BRCA1 tumor suppressor gene." They focused on this gene because an estimated 50 percent of inherited breast cancers are linked to growth errors -- also called mutations -- in this gene. They hypothesized that a specific kind of biochemical modification was involved in disrupting the cell cycle to cause BRCA1 mutations. And they were right.

"With this breast cancer gene, the understanding is that if this gene is mutated it may trigger additional mutations throughout your lifetime and that contributes to a lifetime risk of developing breast cancer. We wanted to understand the molecular mechanism behind this," says Junjie Chen, Ph.D., of the Mayo Clinic Department of Oncology, and lead author of the Science report. "Now that we understand one aspect of it, this allows us to go to the next level, such as how to use our understanding to target cells so we can gain control of the cell cycle to stop cancers."

In the language of science, their principal finding is this: That a specific biochemical modification known as "phosphorylation
'"/>

Contact: Robert Nellis
newsbureau@mayo.edu
507-284-2511
Mayo Clinic
23-Oct-2003


Page: 1 2 3

Related medicine news :

1. Mayo Clinic discovers new pathway against pancreatic cancer
2. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
3. Mayo Clinic study sets threshold for valve repair surgery
4. Mayo Clinic researcher calls for improved newborn screening
5. Mayo Clinic study finds obese kidney donors face few increased risks
6. Mayo Clinic identifies key cellular process in prostate and other cancers
7. Clinical breast examination offers modest benefit to breast cancer screening program
8. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
9. Clinicians report missing patient information is common
10. Mayo Clinic discovers a key to low metabolism and major factor in obesity
11. Clinical trial of Etanercept for Wegeners disease shows no benefit

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mayo Clinic researchers discover how key cancer protein works

(Date:3/2/2015)... March 02, 2015 Four Seasons Resort Maui ... its 25th anniversary this year, having officially opened its doors ... luxury resort is honoring over 70 employees who started on ... from amongst the approximately 400 original employees. The celebration ... Oceanfront Lawn. , This Four Seasons flagship resort, ...
(Date:3/2/2015)... Dhaka, Bangladesh (PRWEB) March 02, 2015 ... appointment of fire safety expert Mark Chubb to serve ... oversee fire safety operations and training in Bangladesh and ... Members source. , “Mark will ensure that the ... and fire safety programs for Bangladesh garment workers,” said ...
(Date:3/2/2015)... 02, 2015 Secura Consultants announced ... with First Protective Insurance Group of Birmingham, AL ... First Protective affiliated advisors to access the enhanced ... Secura Consultants delivers. , Secura Consultants, ... in the design and implementation of insured income ...
(Date:3/1/2015)... Birmingham, Clarkston, Lake Orion, Metamora, Michigan (PRWEB) March 01, 2015 ... BOTOX® , which is approved to treat Overactive Bladder (OAB) ... urgency and frequency in adults when another type of medication ... This is a different treatment option that takes another ... itself. , BOTOX® works on the nerves and ...
(Date:3/1/2015)... Chicago, IL (PRWEB) March 01, 2015 Ticket ... Grateful Dead in Chicago at Soldier Field. Deadheads ... was announced in January. , Grateful Dead was formed 50 ... and they were together as one until the untimely death ... known for combining different genres including blues, reggae, rock, bluegrass, ...
Breaking Medicine News(10 mins):Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Secura Consultants and First Protective Insurance Group Announce Strategic Relationship 2Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2
(Date:3/2/2015)... DUBLIN , Mar. 02, 2015 Research ... announced the addition of the "Lopinavir - ... , Imagine having your own ... of a button. Used by the ... over 10 years, these searches are the benchmark ...
(Date:3/2/2015)... 2015  SI-BONE, Inc., a medical device company that ... of the sacroiliac (SI) joint with the iFuse Implant ... procedures have now been performed world wide utilizing more ... the iFuse procedure continues to grow and gain momentum ... the United States and 17 ...
(Date:3/2/2015)... 2015 Shire plc (LSE: SHP, NASDAQ: ... submitted a New Drug Application (NDA) with the U. S. ... the treatment of signs and symptoms of dry eye disease ... first treatment indicated to address both the signs and symptoms ... millions of people," said Philip J. Vickers , Ph.D., ...
Breaking Medicine Technology:Global Comprehensive Lopinavir Patent Search Online Portal 2015 2SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 2SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 3Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 2Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 3Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 4
Cached News: